19th International

Ultmann Chicago Lymphoma Symposium
April 29 - April 30, 2022

CLS-2021-date

Stay Tuned for Details on the 19th International Ultmann Chicago Lymphoma Symposium

Abstract submissions have closed

Abstracts Close: April 2, 2021 l Abstracts Announced: April 9, 2021 Abstracts should be submitted to: iucls@bioascend.com

Registration Now Open

Submit Your Abstract Today

Abstracts Close: April 2, 2021 l Abstracts Announced: April 9, 2021 Abstracts should be submitted to: iucls@bioascend.com
Dr. John Ultmann

The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.

This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be held virtually on Friday and Saturday and will include a combination of expert presentations, a hematopathology multidisciplinary tumor board discussion, mini symposiums on Indolent lymphoma, Aggressive lymphomas, Primary and Secondary CNS lymphoma, Targeted and Cellular therapies, Imaging, and include a allied healthcare professional session. Additionally, we’ll have a special presentation regarding the impact of COVID-19 on lymphoma treatment.

Virtual symposium components will include:

  • LIVE stream session broadcast in real time
  • Opportunities to submit questions to presenters during the live broadcast
  • Ability to interact with other virtual participants via symposium attendee chat tool
  • Access to the virtual exhibit hall for connectivity and information
  • CME and MOC credits for physicians and CNE credits for nurses
  • Access to download presenter slide decks approved for release

 

Target Audience

The symposium has been designed for medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals committed to the diagnosis and treatment of lymphoma.

Dr. John Ultmann

The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.

This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be held virtually on Friday and Saturday and will include a combination of expert presentations, a hematopathology multidisciplinary tumor board discussion, mini symposiums on Indolent lymphoma, Aggressive lymphomas, Primary and Secondary CNS lymphoma, Targeted and Cellular therapies, Imaging, and include a allied healthcare professional session. Additionally, we’ll have a special presentation regarding the impact of COVID-19 on lymphoma treatment.

Virtual symposium components will include:

  • LIVE stream session broadcast in real time
  • Opportunities to submit questions to presenters during the live broadcast
  • Ability to interact with other virtual participants via symposium attendee chat tool
  • Access to the virtual exhibit hall for connectivity and information
  • CME and MOC credits for physicians and CNE credits for nurses
  • Access to download presenter slide decks approved for release

 

Target Audience

The symposium has been designed for medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals committed to the diagnosis and treatment of lymphoma.

Sonali M. Smith, MD

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
The University of
Chicago Illinois

Andrew M. Evens, DO, MSc, FACP

Professor of Medicine, Rutgers Robert Wood
Johnson Medical School
Associate Director for Clinical Services,
Rutgers Cancer Institute of New Jersey
Director, Lymphoma Program, Division of Blood Disorders
Medical Director, Oncology Service Line,
RWJBarnabas Health
New Brunswick, New Jersey

Barbara Pro, MD

Clinical Director, Lymphoma Program
Professor of Medicine,
Division of Hematology/Oncology
Robert H. Lurie Cancer Center
Northwestern University-Feinberg
School of Medicine Chicago Illinois

Sonali M. Smith, MD

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
The University of
Chicago Illinois

Andrew M. Evens, DO, MSc, FACP

Professor of Medicine, Rutgers Robert Wood
Johnson Medical School
Associate Director for Clinical Services,
Rutgers Cancer Institute of New Jersey
Director, Lymphoma Program, Division of Blood Disorders
Medical Director, Oncology Service Line,
RWJBarnabas Health
New Brunswick, New Jersey

Barbara Pro, MD

Clinical Director, Lymphoma Program
Professor of Medicine,
Division of Hematology/Oncology
Robert H. Lurie Cancer Center
Northwestern University-Feinberg
School of Medicine Chicago Illinois